Screening~History, Physical examination~Vital signs~Laboratory test (Serum AMH, CA-125, HE-4) / EKG / MRI~EHP-30~Intervention~Surgical enucleation or catheter-directed sclerotherapy~Laboratory test / EKG~Adverse event monitoring~Follow-up visit #1 (1 month)~Vital signs~Lab test (AMH, CA-125) / Ultrasound~Adverse event monitoring~Follow-up visit #2 (6 months)~Vital signs~Lab test (AMH, CA-125) / Ultrasound / Contrast-enhanced MRI~EHP-30~Follow-up visit #3 (12months)~Vital signs~Lab test (AMH, CA-125) / Ultrasound~EHP-30
The primary purpose of this study is to compare residual ovarian function and therapeutic efficacy of surgical resection and catheter-directed sclerotherapy for ovarian endometrioma